Delhi close to herd immunity? There’s no consensus yet

New Delhi: Is Delhi headed towards herd immunity against Covid-19? The scientific community is divided on the subject. While some of them feel we are nearly there, as 29% of the city’s population is exposed to the virus that causes the disease already, others say more than 70% of the population has to be exposed before herd immunity can be achieved against the viral infection. Herd immunity refers to a stage in the epidemic when the virus cannot spread widely because there are not enough vulnerable people. ....read more

immuno-Inflammatory features in COVID Patients

The inflammatory changes and immune dysregulation help to identify molecular predictors of COVID-19 severity. For an enriching discussion on immuno-inflammatory features in a COVID 19 patient join us today at 7:00 PM on MEDtalks with Dr K K Aggarwal.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: COVID Preexisting Heart Disease

1053: Update on COVID-19 1054: Meta-analysis evaluates impact of cardiovascular risk profile on COVID-19 outcome Patients with COVID-19 with cardiovascular comorbidities or risk factors have higher odds of developing cardiovascular complications while hospitalized for COVID-19 and have a higher mortality risk, suggests a study published in PLOS One. Investigators from Italy assessed data from 21 published observational studies on 77,317 patients hospitalized for COVID-19 in Asia, Europe, and the United States. ....read more

World Covid Meter 20th August, Acute immuno-inflammatory manageable virus disease with significant post viral phase, 213 Countries Affected

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity India-Brazil difference 20000 per day, or one lac in 4-5 days ,Total difference about 6.3 lac,In one month, India may cross Brazil ....read more

Negative Thoughts are Absence of Positive Thoughts

Darkness cannot be removed physically; it can only be removed by switching on the light or going into sunlight or lighting a fire. Similarly, negative thoughts are absence of positive thoughts. In Bhagavad Gita, it has been said that in the period of Uttarayana with longer days, the first half at full moon, in the presence of light or agni, more positive thoughts are acquired compared to in Dakshinayana, before Amavasya or no moon or in absence of light. Bhagavad Gita also says that whatever you think the whole life, you think at the time of death and if at the time of death you have positive thoughts, you are likely to get Moksha. This could be the reason why in Hindu mythology it is said that just before the death, we should light a diya or chant in front of agni (fire) so that dying person’s thoughts become positive. ....read more

Healthcare News Monitor

Indian pharma industry to play a major role in ‘Atmanirbhar Bharat’, says Goyal

Business Line

Covid-19 period has been a learning experience for the pharmaceutical, medical equipment industry, says the Minister Commerce & Industry Minister Piyush Goyal has asked the pharmaceuticals and medical equipment manufacturing industry to keep up their contribution towards making India self-reliant in health and become a reliable global player. “No doubt all of you have made the nation proud and showed to the world that India can be a trusted partner in trade,” Goyal said talking about the performance of the medical industry during the Covid-19 crisis on Thursday. The Minister was speaking at a CII conference on health.

Cipla, Stempeutics collaborate to launch Stempeucel for CLI treatment in India

THE NEWS SCROLL

New Delhi, Aug 20 (PTI) Pharma major Cipla on Thursday said it is collaborating with its partner Stempeutics Research to launch the latters cell therapy product Stempeucel for the treatment of critical limb ischemia (CLI) in India. The companys partner Stempeutics Research has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel in India, Cipla and Stempeutics said in a joint statement. The product is indicated for the treatment of CLI due to Buergers disease and atherosclerotic peripheral arterial disease, it added. "Under the agreement signed between the two companies, Cipla has received exclusive rights to market and distribute the product in India by leveraging its expansive distribution strengths across the country," the statement said.

Challenges Faced By The Indian Healthcare System

Business Word

The robust transformation of India’s Public Healthcare System witnessed in the past few decades has not only been progressive but also an example for the developing economies of the world. The healthcare system in India can be divided into two parts viz urban and rural areas and both have a significant differential gap in terms of treatment, not because of uncommon diseases but due to lack of adequate infrastructure and health experts, besides several other challenges in the system. However, the objective in this article is to bring out the challenges which the public and private healthcare systems are currently confronting with. Fund Allocation & Inadequate Infra The gap in fund management by the administrations should be understood and be balanced. Not enough funds are allocated for public healthcare in India and the inequality in urban and rural facilities is well known. Due to the lack of modern quality healthcare in the public sector, generally, people prefer private healthcare which is not affordable for most of the rural population due to lower-income and lack of basic insurance policy. Private healthcare in India is a premium and expensive affair for a large section of society. Notably expensive medical device is procured but basic infra is missing in public healthcare system.

Show cause notice against Dhanbad doctor

The Telegraph Online

Taking note of the charges of dereliction of duty with regard to Covid, Dhanbad deputy commissioner Uma Shankar Singh today stopped the salary of medical officer-in-charge of Nirsa, Dr Ila Roy and served a show cause notice against her, directing her to submit a reply within 24 hours. The specific action was taken due to gross negligence by the MOIC during the two-day special Rapid Antibody Test drive conducted on August 16 and 17. Roy did not provide any information regarding the attendance of medical staff and reporting time with regard to a second special Rapid Antibody Test drive, which began on Thursday in different parts of the district, including in Nirsa blocks.